India is a cornerstone of Fette Compacting's global strategy

Ashok Gourish, Managing Director, Fette Compacting India, discusses India's pivotal role in the company's global growth, backed by expanded services, digital transformation support, and a strengthened Competence Center in Goa, in conversation with Express Pharma

- 

How does Fette Compacting view India's role in its global growth strategy? What are your priorities for the Indian market over the next few years?

Ashok Gourish: India is a cornerstone of Fette Compacting's global strategy. As one of the largest producers of generic pharmaceuticals and a rapidly growing hub for nutraceuticals, India offers a unique blend of scale, innovation, and ambition. Our approach is guided by our strategy, “Together – from lab to production”, which reflects our commitment to supporting customers across the entire product lifecycle. We are expanding our service network and strengthening our Competence Center in Goa to provide advanced training, process emulation, and expert guidance. These initiatives ensure that Indian manufacturers have access to the knowledge, tools, and digital solutions needed to optimise efficiency, enhance compliance, and embrace Pharma 4.0. Our goal is to be a trusted partner in India's journey toward smarter, safer, and more sustainable pharmaceutical production.

How is Fette Compacting supporting Indian manufacturers in adopting advanced tablet production technologies?